Next Generation Sequencing Market to Reflect Impressive Growth Rate by 2023

Next generation sequencing (NGS) also known as high-throughput sequencing enables scientists to sequence and assemble billions of short DNA reads. The advent of next generation sequencing technologies has brought significant changes in the sequencing process by providing high throughput, speed, flexibility and reduced sequencing cost over thousand folds. NGS has ability to generate hundreds of gigabases of nucleotide sequence data in a single sequencing run. The technology is emerging at a rapid rate due to its growing adoption in clinical applications as it allows scanning of whole genomes or targeted genomes in less span of time. In addition, reduction in cost of sequencing has also expanded the usage of next generation sequencing in variety of clinical applications. The technique has imparted its usage in various clinical applications such as cancer, inherited genetic disorders, HLA typing and identification of infectious diseases. For instance, NGS has been used for tracing hospital acquired infections and tuberculosis outbreaks.

The market for next generation sequencing can be segmented based on technology, application, end-users and geography. The application section can be categorized into drug discovery, personalized medicines, biomarker discovery, diagnostics and others (agriculture, animal, marine and other studies). The technology section of the market could be subdivided into sequencing by synthesis, ion semiconductor sequencing, pyrosequencing, sequencing by ligation and single molecule real time sequencing. The next generation sequencing market can also be analyzed based on the end user segment including hospitals and clinics, research institutions and pharmaceutical and biotechnology companies. It is witnessed that more than 65% of the next generation sequencing revenue is generated from academic institutions, biopharmaceutical companies and government research institutes. Geographically, the market is segmented into North America, Europe, Asia-Pacific, Latin America (LATAM), and Middle East and Africa (MENA). Of all the geographies, North America accounted for the largest market share in 2014 followed by Europe. However, during the forecast period Asia-Pacific region is anticipated to record highest growth owing to market saturation in developed regions. Furthermore, technological innovation, increasing drug discovery initiatives by healthcare companies, increasing adoption of innovative models and huge capital investment by pharmaceutical and biotechnology companies are some of the key factors expected to drive the growth of next generation sequencing market in Asia.

Currently, the next generation sequencing market is consolidated with very few market players due to involvement of extremely complicated technologies and the low target audience for the systems. The expensive next-generation sequencing systems may exceed a cost of millions of dollars for installation, maintenance, reagents and output analysis. Most respondents have suggested sequencing as a service business rather than an investment for in-house research. Introduction of bench-top sequencers enabling ease of use to researchers is also expected to push the market growth further. Outsourcing sequencing is expected to remain a major contributor to the revenue generation in the coming years. Response gathered from research facilities suggest that purchase of these sequencing platforms may demonstrate actual growth post reduction in the sequencing costs below USD 1000 as suggested by several manufacturers. True potential of this technology lies in the personalized medicine and sequencing genomes of individuals. Furthermore, increasing initiatives by government bodies for genomics research would also boost the adoption of high-throughput sequencing platform.

Some of the major players operating in the global NGS market are Agilent Technologies, Life Sciences Corporation (Roche Holding Ag), Genomatix Software Gmbh, Illumina, Inc., Gatc Biotech Ag, Dnastar, Inc., Life Technologies Corporation, Oxford Nanopore Technologies, Ltd., Perkin Elmer, Inc., Qiagen N.V., Partek Incorporated, Macrogen, Inc., Knome, Inc., and Genomatix Software Gmbh.

Shreyas is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Drug Allergy Market Size, Share, Development, Growth and Demand Forecast to 2023

marketresearchfuture

Drug Allergy is a standout amongst the most widely recognized sorts of hypersensitivities. It is the extreme touchiness of the safe framework to medication or drug. Any sorts of medications, for example, medicine, nonprescription or home grown can prompt Drug Allergy. Some basic manifestations of the medication sensitivities are hives, skin rash, tingling of the eyes or skin, swelling of the face, lips, or tongue, wheezing, and others. Treatment can ease and anticipate extreme responses.

Expanding mindfulness about different hypersensitivities, the presentation of the new treatment of items and rising interest from developing markets drives the development of the worldwide market. New research to forestall sedate hypersensitivities is another key driver for the market. The worldwide Drug Allergy Market is developing respectably and is required to proceed with its development over the figure time frame.

The global Drug Allergy Market is expected to grow at the CAGR of ~5.1% during the forecast period and is estimated to reach USD 4764.0 million by 2023.

Competitive Analysis:

Some of the key players in this market: AstraZeneca (UK), Bayer (US), Circassia (US), HAL Allergy Group (the Netherlands), Johnson & Johnson Services, Inc. (US), MAGNA Pharmaceuticals, Inc. (US), Stallergenes Greer (UK), and others.

Regional Analysis of the Global Drug Allergy Market:

The Americas dominate the global market for the drug allergy. The Americas mainly include North America and Latin America, out of which North America accounts for the majority of the market share of this region. The US is the top revenue generating market in North America and is one of the important markets for the global drug allergy treatment. Approximately 10% of the total US population have drug allergies. Latin America drug allergy market is also growing significantly and mainly includes Brazil, Argentina, and Chile. Europe is the second largest market in the globe owing to increasing cases of drug allergy.

Europe is mainly divided into Eastern Europe and Western Europe. More developed Western European countries like Germany, UK and France are dominating this market while East European region is also growing significantly. Increasing cases of drug allergies are one of the major factors for the growth of the Europe market.

Asia Pacific region is showing the fastest growth rate in the global drug allergy market due to some major factors such as increasing awareness about various drug allergies, availability of treatment products, and rapidly improving healthcare facilities. Japan is holding the major market share while China’s Drug Allergy Industry is expected to show the fastest growth in this region. Changing healthcare practices and increasing patient involvement play an important role in the growth of this market.

The Middle East & Africa is expected to experience a limited growth due to lack of awareness about diseases, traditional healthcare practices, etc. The Middle East region dominates the market due to some of the major factors, for instance, developed healthcare facilities and government support to improve public health.

Brief TOC

  1. Report Prologue
  2. Introduction
  3. Research Methodology
  4. Market Dynamics
  5. Market Factor Analysis
  6. Global Drug Allergy Market By Type
  7. Global Drug Allergy Market By Diagnosis
  8. Global Drug Allergy Market By Treatment
  9. Global Drug Allergy Market By End User
  10. Global Drug Allergy Market By Region
  11. Competitive Landscape
  12. Company Profile
  13. Conclusion
  14. Appendix

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Folliculitis Industry Analysis and Global Forecast to 2023

marketresearchfuture

Folliculitis is very common health problems across the globe. About 3 million cases found per year in the US alone. Folliculitis can be noninfectious or infectious. Although, most of the cases of folliculitis are infectious. Increasing knowledge of folliculitis, rapid adoption of products, and increasing healthcare expenditure are driving this market. Global Folliculitis Market which is expected to grow at the CAGR of ~4.7% during the forecast period and is estimated to reach USD 561.3 million by 2023.

Competitive Landscapes:

Some of the key players in this market are: AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), CELGENE CORPORATION (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Pfizer Inc.(US), and others.

The report for Global Folliculitis Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions

Regional Analysis of Global Folliculitis Market:

Considering the worldwide situation of Folliculitis Industry, the Americas is holding biggest piece of the overall industry. Some central point are driving the development in America, for example, extensive measure of cash put resources into R&D, and clinical trials. European market is second biggest and nations like Germany and UK are holding biggest piece of the pie. Expanding human services spending is main consideration for Asia Pacific folliculitis Market. While because of absence of information of the illness and constrained access to the social insurance offices, Middle East and Africa is developing slower than the worldwide normal.

Brief TOC

  1. Report Prologue
  2. Introduction
  3. Research Methodology
  4. Market Dynamics
  5. Market Factor Analysis
  6. Global Folliculitis Market By Type
  7. Global Folliculitis Market By Treatment
  8. Global Folliculitis Market By End User
  9. Global Folliculitis Market By Region
  10. Competitive Landscape
  11. Company Profile
  12. Conclusion
  13. Appendix

About Us:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Salivary Gland Infection Market by Key Players, Growth, Regions and Forecast to 2023

marketresearchfuture

Salivary gland infection is a standout amongst the most well-known restorative condition over the globe. These diseases are for the most part caused because of microscopic organisms or infections. Salivary organ disease influences salivary conduit or organ.

The Global Salivary Gland Infection Market is growing moderately. Expanding predominance of different Salivary gland infection, changing infection designs, and natural changes are significant drivers for the market development. Rising subsidizing for R&D and clinical trials are prompting enhanced item improvement is another key factor for advertise development. Enhanced cleanliness works on, developing mindfulness about self-mind and propelled finding and treatment alternatives are essential main impetuses for the market.

The global Salivary Gland Infection Market is growing at the CAGR of ~6.7% during the forecast period and expected to reach US$ 3622.6 million by 2023.

Top Key Players of this Market:

Some of the key players in this market are: AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), FUJIFILM Holdings Corporation (Japan), General Electric Company (US), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Pfizer Inc.(US), Siemens Healthcare GmbH (Germany), and others

Segments: 

Global salivary gland infection market has been segmented on the basis of diagnosis which comprises of Plain radiography, sialography, high-resolution ultrasonography, Computed tomography (CT), Magnetic Resonance Imaging (MRI), radionuclide scintigraphy, and others. Sialography is further sub-segmented into CT sialography (ultrafast technique), fluoroscopic/conventional sialography (with or without digital subtraction), and MR sialography.

On the basis of treatment, the market has been segmented into medication, surgery, aspiration, home care, and others. Medication is further sub-segmented into antibiotics and others. Antibiotics are further sub-segmented into dicloxacillin, cephalosporins, clindamycin, and others. Surgery includes removal of part of the parotid salivary gland, removal of all of the parotid salivary gland, removal of the submandibular salivary gland, and others. Home remedies include increased water intake, rest, refraining from smoking, massaging the gland with heat, and others.

On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.

The report for Global Salivary Gland Infection Industry of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.

Brief TOC

  1. Report Prologue
  2. Introduction
  3. Research Methodology
  4. Market Dynamics
  5. Market Factor Analysis
  6. Global Salivary Gland Infection Market By Diagnosis
  7. Global Salivary Gland Infection Market By Treatment
  8. Global Salivary Gland Infection Market By End User
  9. Global Salivary Gland Infection Market By Region
  10. Competitive Landscape
  11. Company Profile
  12. Conclusion
  13. Appendix

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Surgical Equipment Market by Key Players, Growth, Regions and Forecast to 2021

marketresearchfuture

A Surgical Equipment is a specially designed tool or device for performing specific actions of carrying out desired effects during a surgery or operation, such as modifying biological tissue, or to provide access for viewing it. Over time, many different kinds of Surgical Equipment s and tools have been invented. Some Surgical Equipment s are designed for general use in surgery, while others are designed for a specific procedure or surgery. Accordingly, the nomenclature of Surgical Equipment s follows certain patterns, such as a description of the action it performs (for example, scalpel, and hemostat), the name of its inventor(s) (for example, the Kocher forceps) or a compound scientific name related to the kind of surgery. The Surgical Equipment Market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

Global Surgical Equipment Market– Forecast to 2021 The report firstly introduced Global Surgical Equipment Market including classification, application and industry chain overview; Then we deeply analyzed global growth forecast indicators by the as well as the regional market conditions that including the product price, profit, utilization, supply, demand and industry growth rate etc.

In the end, the report introduced Surgical Equipment market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Global Surgical Equipment Market. We are thankful for the support and assistance from Global Surgical Equipment Market. Industry chain related technical experts and marketing experts during Research Team survey and interviews.

The report for Global Surgical Equipment Industry of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Brief TOC

  1. Introduction
  2. Research Methodology
  3. Report Excerpt
  4. Forecast Indicators
  5. Market Analysis
  6. Global Surgical Equipment Market, By Type
  7. Geographical Explorations
  8. Competitive Analysis
  9. Company Profiles
  10. Appendix

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Safety Lancet Market-Outlook, Regulatory Bodies, Trends, Industry Insights & Forecast

marketresearchfuture

Safety lancet is a disposable contrivance used for collecting capillary blood samples by doctors or other medical professionals. This is an intact object to the prevention from needle injury problems. Safety lancet eradicates the injuries and infections caused by injections. The global Safety Lancet Market is projected to reach USD 2,305.1 million in 2023 from USD 1,056.2 million in 2016 with a CAGR of 11.8% during the forecast period 2017-2023.

The cost of safety lancet is really high. So as a result though it is painless and hazardless people from undeveloped countries can’t afford them. Countries like Africa where there is scarcity of food people can’t even think about adopting this new innovative technology. Other than this another factor demolishing the market growth of safety lancet is that it is not always available. This availability problem is somehow hindering the growth of Safety Lancet Market.

Safety Lancet Market-Overview:

Various reasons are helping behind the grand success of safety lancet market. The safety lancet becomes automatically inactive after it is used once. So there is no way to use it twice. This helps the doctors to maintain proper hygiene needed for the patient as a result patients are highly demanding for the use of safety lancet which is further propelling the market growth. Safety lancet contains self-retracting needles which reduces the hazard of cross contamination and other needle related injuries. Safety lancet is created in a way that it goes slightly under the skin and pulls as much of blood is required without leaving some deep injuries inside the skin. This is a great option for those who has fear in needle, as a result hospitals are hugely adopting this safety lancet.  Another aspect helping the acceptance of safety lancet in market is that this has high speed penetration which helps to abbreviate the pain which comes from regular injections. The sharp injury prevention aspect of safety lancet is expanding its market growth globally.

Safety Lancet Market- Regional Analysis:

Asia Pacific has countries like India, China where high population is giving rise to the adoption of safety lancet. South Korea has done some huge advancement which is working as a reason behind the huge growth of Safety Lancet Industry in Asia Pacific.

North America is massively contributing in the market growth of safety lancet market. Health care clinics and hospitals in US are considerably adopting this new medical technology as patients over there are highly aware about hygiene. Europe is also contributing in the market growth of safety lancet. Germany, France and Italy are embracing this safety lancet in their hospitals and clinics.

Safety Lancet Market-Competitive Analysis:

In 2007, GMMC chucked the LANZO lancing device and in 2011 GMMC initiated LANZO safety lancet and is recognized among the best suppliers of safety lancet in Korean market.

Major contributors in this market are: F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Terumo Medical Corporation, Bayer AG, HTL-STREFA S.A., Sarstedt AG & Co., Improve Medical Technology Co. Ltd and others.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Next-Generation IV Infusion Pumps Market is Anticipated to Collect of US$ 3.2 Bn by 2025 End

Persistence Market Research has carried out a detailed market research on next-generation IV infusion pumps and has presented vital insights based on the market analyses in its research publication titled “Next-Generation IV Infusion Pumps Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”. This research report covers various macro-economic aspects influencing the growth of the next generation IV infusion pumps market along with various trends, opportunities, restraints and drivers impacting the market. These impacting factors are scrutinized across important regions considering all major market segments.

The global next-generation IV infusion pumps market has been thoroughly analyzed and is anticipated to grow at a robust CAGR of 5.4% throughout the period of forecast 2017-2025. The global market is estimated to reach a value of about US$ 3.2 Bn in 2025 from a value of around US$ 2 Bn in 2016. This market has witnessed a positive growth path since 2012 and it is poised to continue over the following years.

Expanding production base for smart PCA, ambulatory and syringe pumps in developing economies and rising adoption of smart pumps with huge drug libraries are opportunities that can be tapped by players involved in the global next-generation IV infusion pumps market. Emerging economies offer high opportunities as they register high rate of spread of chronic diseases. The advancements in IV infusion pumps systems, increasing research and development infrastructure due to rising investments and expenditure on research and development, favorable reimbursement for infusion therapy, rising demand for ambulatory infusion pumps, increasing strategic collaborations among leading players, improvement in distribution channel, ease in FDA approvals and clearance, strong government support for start-ups, expanding production capacity and extension of product line coupled with expanding medical device infrastructure and growing adoption of advanced medical devices have strongly supported the growth of the next-generation IV infusion pumps market. Medicine dispensing errors, product recalls due to product errors, lack of skilled personnel and lack of standard usage guidelines are few aspects which pull the adoption of next-generation IV infusion pumps thus having a negative impact on the global next-generation IV infusion pumps market.

The global next-generation IV infusion pumps market has been categorized by product type, by application, by end user and by region.

  • By region, Asia Pacific is expected to witness high growth as compared to other regions, and is poised to reach a significant market share with a high CAGR of 7.8% throughout the period of forecast 2017-2025. North America region stays ahead with respect to market value to dominate the global next-generation IV infusion pumps market by region followed by Europe
  • Chemotherapy segment by application is the fastest growing segment and is expected to reflect high market valuation by the end of 2025. This segment is projected to grow at a CAGR of 7.1% throughout the forecast period to attain an estimated value of about US$ 1.1 Bn in 2025
  • Hospitals segment by end user dominates the global market and also poised to reflect a high CAGR of 6.0% during the assessment period due to rise in adoption of infusion pumps in hospitals
  • Large volumetric infusion systems to lead the global next-generation IV infusion pumps market by product type to reach a market value of about US$ 1.1 Bn in 2025. Electronic ambulatory infusion systems product segment is poised to show high potential in the coming years

The global next-generation IV infusion pumps market research report covers key players involved in the  market such as B. Braun Melsungen AG., Becton, Dickinson Company, Fresenius Kabi AG, Terumo Corporation, Medtronic Plc., Baxter International Inc., Hospira, Inc., iRadimed Corporation, Zyno Medical, Nipro Corporation, Ambu A/S, Summit Medical Products, Inc., Smiths Medical, vTitan and Gamastech s.r.l.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Neurointerventional Devices Market to Report a CAGR of 4.8% Between 2015 and 2025

futuremarketinsights_logo

Future Market Insights (FMI), in its latest report titled, “Neurointerventional Devices Market: Global Industry Analysis and Opportunity Assessment 2015 – 2025”, has projected global neurointerventional devices market to expand at a CAGR of 4.8% during the forecast period (2015-2025).

As per the Society of Neurointerventional Surgery, neurointervention is a treatment approach to conditions occurring within the blood vessels of the brain or in the spinal cavity. This procedure is highly performed by neuro-specialists due to its safety, minimally-invasive technique and comparatively higher success rate ratio as compared to conventional clipping method.

Global neurointerventional devices market is estimated to account for US$ 1,766.8 Mn by the end of 2015, mainly driven by rising demand from end-use segments.

The report analyses the global neurointerventional devices market in terms of market value (US$ Mn) and market volume (units) by product type, region, end-user and technique, and provides information regarding market dynamics, regulatory compliances, competitive landscape, current trends, market estimations and forecast for the market.

Adoption rate of neurointervention devices among neurosurgeons/neuro-specialists has increased significantly owing to the technological advancements and benefits these devices offer. These devices, especially metal coils and catheters, are highly preferred by neurosurgeons. Increasing geriatric population globally is also expected to boost overall demand for neurointerventional devices. These devices find wide application in Japan and countries in developed regions such as Western Europe and North America. However, these devices are expected to gain popularity in Latin America and Asia Pacific excluding Japan (APEJ) in the near future. High cost along with negative perception about certain neurointervention devices are factors that are expected to act as growth restraints in the future, and some devices approval by FDA have also faced criticism for performance.

North America is expected to dominate the global market throughout 2025 and is projected to witness 1.6X increase in volume over the forecast period. The U.S is expected to dominate the North America neurointerventional devices market throughout the forecast period. However, the U.S. market is projected to lose significant amount of its market value share to Canada by the end of forecast period. North America is a major neurovascular market. The region is expected to witness launch of various new products, with increasing number of players expected to enter into the market over the following five years. Japan is the next most lucrative market for neurovascular companies; however, the market in the region is projected to witness below average CAGR of 3.9% during the forecast period.

Among product types, embolic coils product segment is expected to dominate the global neurointerventional devices market, followed by the neurothrombectomy product segment. Increasing incidence of brain aneurysm is expected to boost overall demand for embolic coils albeit, at a comparatively lower pace. Flow diverters and stent retrievers are gaining wide recognition among neurointerventionists. Stent retrievers segment is expected to witness impressive growth in the U.S. market over the following five years. Global stent retrievers segment is expected to witness 2X increase in value over the forecast period.

On the basis of technique, neurointervention devices market is segmented into neurothrombectomy procedure, cerebral angiography, stenting, coiling procedures and flow disruption. Coiling procedure segment is expected to dominate the overall neurointerventional devices market by the end of forecast period. The segment is projected to register average growth rate over the forecast period. Flow disruption is projected to be the fastest growing procedure segment. Increasing adoption of flow diverters among neurointervention is fuelling growth of the procedure segment.

On the basis of end use, the market has been segmented into hospitals and ambulatory surgical centers. Hospitals segment accounts for major share of the neurointerventional devices market.

Key market participants covered in the report include Medtronic, Penumbra Inc., Stryker Corporation, Terumo Corporation, and Johnson & Johnson.

About Us 

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

T (UK): +44(0)20-7692-8790

Sales: sales@futuremarketinsights.com

Smita Deshmukh is a veteran digital marketing professional, having worked for numerous online firms in his distinguished career. She believes in continuous learning, considering that the digital marketing sector’s rapidly evolving nature.

8 Predictions on how Ultrasound Systems Market will Expand through 2022

Due to the increasing adoption of advanced imaging systems in healthcare industry, ultrasound systems continue to be an irreplaceable commodity. In the view of rising healthcare costs, affordable and accurate imaging & diagnosis achieved through ultrasound technology will continue to attract patients, and render profits even in conventional medical settings. Fact.MR’s report on the global market for ultrasound systems projects a steady growth for the market during 2017-2022. The global ultrasound systems market, which is pegged to reach US$ 6 Bn by 2017-end, will soar steadily at a 5.5% CAGR to reach US$ 7.8 Bn towards the end of 2022.

Following are key projections on the global ultrasound systems market, excerpted from the report:

  1. The report highlights the application of ultrasound systems in cardiology. Alarming rise in incidence of cardiac disorders throughout the globe is expected to drive the adoption of ultrasound systems, which are effectively used in cardiology diagnostics. Between 2017 and 2022, more than US$ 430 Mn worth of incremental opportunity will be created by application of ultrasound systems in cardiology. The report also predicts that nearly half of ultrasound systems sold in the global market during the forecast period will be developed on 2D ultrasound imaging technology.
  2. Healthcare infrastructure in developed economies such as the US and Canada is expected to promote the adoption of ultrasound systems. The report projects that by the end of 2022, North America’s ultrasound systems market will have reached an estimated value of US$ 3.2 Bn. During this forecast period, North America is also anticipated to be the largest market for ultrasound systems in the world.
  3. The report also observes impressive growth in the ultrasound systems market across European countries. In 2017, more than 25% of the global ultrasound systems market value is expected to be accounted by sales of ultrasound systems in Europe.
  4. Demand for ultrasound systems in the Asia-Pacific excluding Japan (APEJ) region is projected to be lower than above regions, however, manufacturers will be interested in laying down their production units in this region. In such manner, the APEJ ultrasound systems market is likely to account for more than 15% of the global market revenues throughout the forecast period.
  5. Based on the portability of ultrasound systems, the report expects a higher demand for standalone systems. By procuring revenues worth US$ 4.2 Bn, standalone ultrasound systems will dominate the global market with more than 70% revenue share towards the end of 2017. On the other hand, portable ultrasound systems will showcase a robust revenue growth at 6.4% CAGR, albeit, reflecting a little over 17% share on the global ultrasound systems market.
  6. Hospitals will remain the largest end-users of ultrasound systems in the global market, and account for half of its value in the years to come. Meanwhile, diagnostic centers will contribute to nearly 20% of the global ultrasound systems market, procuring revenues worth US$ 1.6 Bn by 2022-end.

The report has profiled leading players in the global ultrasound systems market, which include companies namely, General Electric Company, Koninklijke Philips N.V., Toshiba Corporation, Siemens AG, Hitachi Ltd., Fujifilm Holdings Corporation, Esaote SpA., Shimadzu Corporation, Analogic Corporation, and Samsung Electronics Co. Ltd.

About Fact.MR       
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

Outpatient Clinics Market Will Likely to Expand at a Steady CAGR of 4.3% by 2027

futuremarketinsights_logo

Growing advancements in medical technology has led to development of treatment techniques and medications that do not require the patients to stay for long hours at the clinics or hospitals. However, imposition of strict regulations will continue to hinder the global market growth of outpatient disorders over the forecast period. Future Market Insights states that the global market of outpatient clinics is projected to reflect a CAGR of 4.3%, representing more than US$ 39,000 Mn by 2022-end.

Factors Fuelling Global Market Growth

Growth of the global outpatient clinics market is mainly bound to various macro-economic and micro-economic factors. Prevalence of chronic diseases such as asthma, diabetes, depression and congestive heart failures lead to complex and severe health problems. With the escalating cost of treatment process in various healthcare organizations, patients prefer visiting the outpatient clinics for accessing treatment. Growing concerns regarding the increasing prevalence of cardiovascular diseases such as elevated blood pressure levels, hypertension, coronary heart diseases and cerebrovascular diseases has further led to surge in demand for the outpatient clinics globally.

Demand for quick and effective treatment of cardiovascular diseases will continue to contribute towards the global market growth of outpatient disorders. According to a recently published report by CDC, nearly 610,000 people die of heart attack in the U.S. each year, which is 1 in every 4 deaths. As cardiovascular diseases continue to remain a leading cause of mortality globally, demand for effective and quick treatment process will continue to remain high. These factors are projected to impact the global market growth of outpatient clinics throughout the forecast period.

Collaborations among the private insurance companies and outpatient clinics will continue to remain a major trend in the global market. Through collaborations the private insurance companies offer payment and services in outpatient clinics. Imposition of regulations such as Health Care and Educational Reconciliation Act and Patient Care Affordable Act provides the U.S. citizens with the public health insurance coverage and offers access to private health insurance services. Moreover, increasing employee benefits such as Employees’ health insurance by the employers is projected to contribute towards the global market growth of outpatient clinics over the forecast period.

However, the global market of outpatient clinics will continue to witness inhibiting growth attributed to various factors. Imposition of strict regulations and limited number of doctors for the treatment of various diseases will remain a key factor inhibiting demand for services offered by outpatient clinics. As the patients are not monitored for a long period of time, risk of addiction to alcohol and drugs is projected to remain high. Moreover, lack of access to counselors in comparison to the residential and inpatient facility is further projected to impede the global market growth of outpatient clinics.

Sales to Remain High Through Cardiology Specialty Areas

Prevalence of chronic and cardiovascular disorders is projected to fuel demand for the multi-specialty centers globally. In terms of revenue, the multi-specialty center type segment is projected to witness significant growth, representing more than US$ 8,400 Mn by 2022-end. Moreover, the multi-specialty center type segment is projected to reflect the fastest growth in the global market of outpatient clinics throughout the forecast period.

On the basis of specialty type, the dermatology segment is projected to reflect a significant CAGR through 2022. However, the cardiology specialty areas segment is projected to represent a robust revenue growth, recording more than US$ 3,000 Mn over the forecast period.

Market Players

Major players in the global market of outpatient clinics are Kaiser Permanente Inc., M D Anderson Cancer Center, Mayo Clinic, Memorial Sloan Kettering, University of Maryland Medical Center, DaVita Inc., Cleveland Clinic, Fresenius Medical Care and Johns Hopkins Medicine.

About Us 

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

T (UK): +44(0)20-7692-8790

Sales: sales@futuremarketinsights.com

Smita Deshmukh is a veteran digital marketing professional, having worked for numerous online firms in his distinguished career. She believes in continuous learning, considering that the digital marketing sector’s rapidly evolving nature.